Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study - The Lancet Oncology
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine
Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium - The Lancet Oncology
Frontiers | Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
Digital clinical trials: a new era - LaingBuisson News
Clinical trial - Wikipedia
Design of a “Lean” Case Report Form for Heart Failure Therapeutic Development - ScienceDirect
IKCS 2022: The New Era of Clinical Trials: Meeting Regulatory Requirements and Decreasing Barriers
Circulation: Heart Failure | AHA/ASA Journals
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
PDF) Patient-reported outcomes: A new era in clinical research
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology
Patient-Reported Outcomes | Rethinking Clinical Trials®
